The everolimus eluting Synergy Megatron TM drug-eluting stent platform: Early outcomes from the European Synergy Megatron TM Implanters' Registry.
Kalpa De SilvaMatthew Emile LiKamWaTim WellsAbdul MozidAndrew LadwiniecBrian G HynesAshish KotechaKarim RatibSinjini BiswasNicolas AmabilePierre DeharoMargaret McEntagartJames C S SprattFranck DigneMeadhbh HoggJonathan A MaileySimon J WalshSundeep S KalraPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2023)
everolimus eluting stent in a 'real-world' setting shows favorable outcomes at 30 days and 1 year.